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Abstract
Routine screening for gastroesophageal varices in liver cirrhosis is necessary. At pres-
ent, upper gastrointestinal endoscopy is the golden diagnostic test of gastroesophageal 
varices. However, the use of upper gastrointestinal endoscopy is restricted because of its 
poor compliance and adverse events. In this chapter, we reviewed the recent evidence 
regarding the value of noninvasive or less invasive tests for the diagnosis of gastroesoph-
ageal varices in liver cirrhosis.
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1. Introduction
Gastroesophageal varices and their related bleeding are one of the most common and lethal 
complications of liver cirrhosis [1, 2]. The prevalence of gastroesophageal varices is approxi-
mately 50% at the diagnosis of liver cirrhosis [2]. In the absence of any interventions, Groszmann 
et al. reported that the incidence of confirmed small varices, large varices, and variceal bleed-
ing in patients without any previous history of varices was 28.6, 3.8, and 2.9% during a median 
duration of follow-up of 54.9 months, respectively [3]. Merli et al. reported that the 1-, 2-, and 
3-year incidence of varices in cirrhotic patients without varices was 5, 17, and 28%, respectively 
[4]. In this chapter, we mainly review the following contents: the practice guideline and con-
sensus recommendations regarding screening for gastroesophageal varices in liver cirrhosis, 
current understanding regarding alternative diagnostic tests of gastroesophageal varices in 
liver cirrhosis, and diagnostic accuracy of different alternative diagnostic tests.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Screening for gastroesophageal varices in liver cirrhosis
Upper gastrointestinal endoscopy is the golden diagnostic test of gastroesophageal varices. 
There are some recommendations from practice guideline and consensus regarding endo-
scopic screening for gastroesophageal varices in liver cirrhosis.
According to the UK practice guideline on the management of variceal hemorrhage in cir-
rhotic patients, there are high levels of evidence regarding the surveillance of gastroesopha-
geal varices in liver cirrhosis [5]. First, all patients with cirrhosis should undergo endoscopy 
at the time of diagnosis. Second, in the absence of varices, patients with cirrhosis should 
undergo endoscopy every 2–3 years. Third, in the cases of grade I varices, patients with cir-
rhosis should undergo endoscopy every year. Fourth, in the cases of disease progression, the 
intervals of endoscopy can be modified by the clinicians.
According to the Baveno VI consensus workshop, there are low levels of evidence and weak 
grade of recommendation regarding the surveillance of esophageal varices in liver cirrho-
sis [6]. First, compensated cirrhosis without ongoing liver injury or varices should undergo 
endoscopy every 3 years. Second, compensated cirrhosis with ongoing liver injury without 
varices should undergo endoscopy every 2 years. Third, compensated patients with small 
varices without ongoing liver injury should undergo endoscopy every 2 years. Fourth, com-
pensated patients with ongoing liver injury and small varices should undergo endoscopy 
every year.
The recommendations of the 2016 Practice Guidance by the American Association for the 
Study of Liver Diseases are similar to those of the Baveno VI consensus [7]. First, in the 
absence of varices, compensated cirrhosis with and without ongoing liver injury should 
undergo endoscopy every 2 and 3 years, respectively. Second, in the presence of small vari-
ces, compensated cirrhosis with and without ongoing liver injury should undergo endoscopy 
every 1 and 2 years, respectively. Third, compensated cirrhosis should undergo endoscopy at 
the time when decompensation events develop.
Although the recommendations regarding the interval of endoscopy and target population 
are heterogeneous among practice guidelines, repeated endoscopy is necessary for cirrhotic 
patients. However, endoscopic examinations have several limitations. First, nearly all patients 
are reluctant for endoscopy. Patients may have poor complaint regarding endoscopy. Second, 
not all endoscopic examinations are safe. The endoscopy-related adverse events are more 
frequent and severe in patients with cardiovascular and cerebrovascular diseases. 
3. Current knowledge about alternative diagnostic tests of 
gastroesophageal varices in liver cirrhosis
A questionnaire survey assessed the knowledge about alternative diagnostic tests of gastro-
esophageal varices in 42 members from the Gastroenterology Branch of the Liaoning Medical 
Association, China [8]. Indeed, alternative diagnostic tests are rarely or never employed in 
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clinical practice. In the following text, several major alternative diagnostic tests, such as serum 
liver fibrosis parameters, platelet count to spleen diameter ratio (PSR), liver and spleen stiff-
ness, capsule endoscopy, and computed tomography, are reviewed on the basis of major evi-
dence, especially the results of meta-analyses. The data regarding sensitivity and specificity 
are primarily presented.
4. Serum liver fibrosis parameters for diagnosis of gastroesophageal 
varices
Hyaluronic acid (HA), laminin (LN), amino-terminal propeptide of type III procollagen 
(PIIINP), and collagen IV (CIV) are major serum parameters for the assessment of liver fibro-
sis. A retrospective study evaluated their value of diagnosis of gastroesophageal varices [9]. 
Unfortunately, all of them could not accurately predict the presence of gastroesophageal varices.
APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex are the major scores for the assess-
ment of liver fibrosis. Deng et al. systematically reviewed their diagnostic accuracy of gastro-
esophageal varices [10]. The authors found that APRI, AAR, FIB-4, Lok, Forns, and FibroIndex 
scores had been evaluated, but not FI or King score. As for the diagnosis of gastroesophageal 
varices, the sensitivity and specificity of APRI were 0.60 and 0.67, respectively; those of AAR 
were 0.64 and 0.63, respectively; those of Lok were 0.74 and 0.68, respectively; and the area 
under the summary receiver operating characteristic curve of these scores ranged from 0.6774 
to 0.7885. As for the diagnosis of large varices, the sensitivity and specificity of APRI were 
0.65 and 0.66, respectively; those of AAR were 0.68 and 0.58, respectively; those of FIB-4 were 
0.62 and 0.64, respectively; those of Lok were 0.78 and 0.63, respectively; those of Forns were 
0.65 and 0.61, respectively; and the area under the summary receiver operating characteris-
tic curve of these scores ranged from 0.6530 to 0.7448. More recently, a retrospective study 
further confirmed these findings [11]. More importantly, their diagnostic accuracy should be 
improved after the exclusion of previous gastrointestinal bleeding and splenectomy.
5. PSR for diagnosis of gastroesophageal varices
PSR is a ratio of the platelet count (/mm3) to the spleen diameter (mm). Multiple meta-analyses 
evaluated the diagnostic accuracy of PSR for varices. Chawla et al. conducted a meta-analysis 
of eight studies to explore the diagnostic accuracy of PSR with a cut-off value of 909 for the 
presence of esophageal varices in cirrhosis [12]. They found a sensitivity of 0.89 and a speci-
ficity of 0.74, but the evidence was of low quality according to the GRADE rule. Ying et al. 
performed another meta-analysis of 20 studies to assess the value of PSR with a cut-off value 
of 909 for esophageal varices in cirrhosis [13]. By comparison, they showed a relatively higher 
sensitivity of 0.92 and a specificity of 0.87, and the quality of studies was moderate according 
to the quality assessment of diagnostic accuracy studies (QUADAS) questionnaires. More 
recently, Chen et al. reported the results from an updated meta-analysis of 49 studies that the 
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summary sensitivity and specificity of PSR for any varices were 0.84 and 0.78, respectively, 
and that the summary sensitivity and specificity of PSR for high-risk varices were 0.78 and 
0.67, respectively [14]. Similarly, the authors considered that the quality of included studies 
was moderate. Taken together, the evidence supported the use of PSR for identifying the pres-
ence of varices. However, its diagnostic accuracy is not high.
6. Liver and spleen stiffness measurement for diagnosis of 
gastroesophageal varices
Major evidence can be obtained from the results of several large meta-analyses. Pu et al. 
identified a total of 15 papers regarding liver stiffness measurement by FibroScan transient 
elastography for esophageal varices [15]. The pooled sensitivity and specificity of liver stiff-
ness for any varices were 0.84 and 0.62, respectively; the pooled sensitivity and specificity 
of liver stiffness for large varices were 0.78 and 0.76, respectively. Similarly, Qu et al. also 
performed a meta-analysis of 20 studies to evaluate the performance of liver stiffness by tran-
sient elastography for esophageal varices [16]. As for any varices, the pooled sensitivity and 
specificity were 0.84 and 0.68, respectively. As for large varices, the pooled sensitivity and 
specificity were 0.84 and 0.72, respectively. Singh et al. synthesized the data from 12 studies 
regarding spleen stiffness for the diagnosis of esophageal varices [17]. As for any varices, the 
pooled sensitivity and specificity were 0.78 and 0.67, respectively. As for clinically significant 
esophageal varices, the pooled sensitivity and specificity were 0.81 and 0.66, respectively. 
More recently, Ma et al. conducted a meta-analysis of 16 studies to compare the diagnostic 
accuracy of liver vs. spleen stiffness for the diagnosis of gastroesophageal varices [18]. The 
authors found that the sensitivity and specificity of liver stiffness for the diagnosis of gastro-
esophageal varices were 0.83 (95% confidence interval: 0.78–0.87) and 0.66 (95% confidence 
interval: 0.60–0.72), respectively; those of spleen stiffness were 0.88 (95% confidence interval: 
0.83–0.92) and 0.78 (95% confidence interval: 0.73–0.83), respectively. Importantly, the spleen 
stiffness had a significantly higher diagnostic accuracy than the liver stiffness (summary 
receiver operating characteristic curve value: 0.88 vs. 0.81, p < 0.01; diagnostic odds ratio: 
25.73 vs. 9.54, p < 0.01).
7. Capsule endoscopy for diagnosis of gastroesophageal varices
Until now, two meta-analyses were published regarding this topic. In 2014, a Cochrane review 
of 15 studies including 936 patients with liver cirrhosis analyzed the diagnostic performance 
of capsule endoscopy for the diagnosis of esophageal varices [19]. As for any varices, the 
pooled sensitivity and specificity were 0.848 and 0.843, respectively. As for large varices, the 
pooled sensitivity and specificity were 0.737 and 0.905, respectively. More recently, McCarty 
et al. systematically reviewed the data from 17 studies regarding wireless capsule endoscopy 
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for the diagnosis of esophageal varices [20]. As for any varices, the pooled sensitivity and 
specificity were 0.83 and 0.85, respectively. As for medium to large varices, the pooled sensi-
tivity and specificity were 0.72 and 0.91, respectively.
8. Computed tomography scans for diagnosis of gastroesophageal  
varices
There are at least two meta-analyses regarding the value of computed tomography scans for 
the diagnosis of gastroesophageal varices. The first meta-analysis included 11 studies [21]. As 
for esophageal varices, the sensitivity and specificity were 0.896 and 0.723, respectively; as for 
gastric varices, the sensitivity and specificity were 0.955 and 0.658, respectively. The second 
meta-analysis included 17 studies [22]. As for any varices, the sensitivity and specificity were 
0.87 and 0.80, respectively; as for any esophageal varices, the sensitivity and specificity were 
0.87 and 0.81, respectively; as for any gastric varices, the sensitivity and specificity were 0.86 
and 0.79, respectively. As for high-risk varices, the sensitivity and specificity were 0.87 and 
0.88, respectively; as for high-risk esophageal varices, the sensitivity and specificity were 0.87 
and 0.88, respectively; as for high-risk gastric varices, the sensitivity and specificity were 0.83 
and 0.97, respectively. More recently, a retrospective study found that a diameter of esopha-
geal varices of 3.9 mm on computed tomography scans might be the optimal cut-off value for 
the diagnosis of high-risk varices [23].
9. Endoscopic ultrasound
Researchers also explored the value of endoscopic ultrasound in the diagnostic evaluation of 
gastroesophageal varices [24]. Endoscopic ultrasound was inferior to conventional endoscopy 
in the diagnosis and grading of esophageal varices, but superior in the evaluation of para- or 
peri-esophageal veins and gastric varices. More importantly, the detection of para- or peri-
esophageal veins by endoscopic ultrasound predicted the risk of bleeding and outcomes.
10. Conclusions
Alternative diagnostic tests of varices in liver cirrhosis have been widely explored in numer-
ous studies. Several scores for the assessment of liver fibrosis are readily available, but have 
relatively low diagnostic accuracy. PSR and liver and spleen stiffness are noninvasive and 
have moderate diagnostic accuracy. By comparison, contrast-enhanced computed tomogra-
phy and capsule endoscopy have relatively high diagnostic accuracy, but are expensive and 
potentially invasive (exposure to radiation). Thus, a diagnostic algorithm according to the 
cost and diagnostic performance of various diagnostic tests and clinical necessity should be 
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considered. In detail, PSR and liver and spleen stiffness should be the first step for the non-
invasive diagnosis of varices; if a thorough evaluation of severity of liver diseases is simul-
taneously needed, contrast-enhanced computed tomography scans should be preferred and 
arranged earlier; if available, an endoscopic ultrasound can be performed to more accurately 
detect the para- or peri-esophageal veins.
Author details
Xingshun Qi1*, Qiang Zhu2,3 and Ye Tian1
*Address all correspondence to: xingshunqi@126.com
1 Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, 
Liaoning, China
2 Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong 
University, Jinan, Shandong, China
3 Shandong Provincial Engineering and Technological Research Center for Liver Diseases 
Prevention and Control, Jinan, Shandong, China
References
[1] Ge PS, Runyon BA. Treatment of patients with cirrhosis. New England Journal of 
Medicine. 2016;375:767-777.
[2] Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. 
New England Journal of Medicine. 2010;362:823-832.
[3] Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-
blockers to prevent gastroesophageal varices in patients with cirrhosis. New England 
Journal of Medicine. 2005;353:2254-2261.
[4] Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and 
natural history of small esophageal varices in cirrhotic patients. Journal of Hepatology. 
2003;38:266-272.
[5] Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, et al. UK guidelines on 
the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64:1680-1704.
[6] de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI 
Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. 
Journal of Hepatology. 2015;63:743-752.
Liver Cirrhosis - Update and Current Challenges82
[7] Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cir-
rhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the 
American Association for the study of liver diseases. Hepatology. 2017;65:310-335.
[8] Qi X, Guo X, Li H, Liu X, Deng H. Knowledge about non-invasive diagnostic tests for 
varices in liver cirrhosis: A questionnaire survey to the Gastroenterology Branch of the 
Liaoning Medical Association, China. Gastroenterology Report (Oxford). 2016;4:141-147.
[9] Qi X, Li H, Chen J, Xia C, Peng Y, Dai J, et al. Serum liver fibrosis markers for predict-
ing the presence of gastroesophageal varices in liver cirrhosis: A retrospective cross-
sectional study. Gastroenterology Research and Practice. 2015;2015:274534.
[10] Deng H, Qi X, Guo X. Diagnostic accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and 
FibroIndex scores in predicting the presence of esophageal varices in liver cirrhosis: A 
systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e1795.
[11] Deng H, Qi X, Peng Y, Li J, Li H, Zhang Y, et al. Diagnostic accuracy of APRI, AAR, FIB-4, 
FI, and King scores for diagnosis of esophageal varices in liver cirrhosis: A retrospective 
study. Medical Science Monitor. 2015;21:3961-3977.
[12] Chawla S, Katz A, Attar BM, Gupta A, Sandhu DS, Agarwal R. Platelet count/spleen diam-
eter ratio to predict the presence of esophageal varices in patients with cirrhosis: A sys-
tematic review. European Journal of Gastroenterology and Hepatology. 2012;24:431-436.
[13] Ying L, Lin X, Xie ZL, Hu YP, Shi KQ. Performance of platelet count/spleen diameter 
ratio for diagnosis of esophageal varices in cirrhosis: A meta-analysis. Digestive Diseases 
and Sciences. 2012;57:1672-1681.
[14] Chen R, Deng H, Ding X, Xie C, Wang W, Shen Q. Platelet count to spleen diameter ratio 
for the diagnosis of gastroesophageal varices in liver cirrhosis: A systematic review and 
meta-analysis. Gastroenterology Research and Practice. 2017:7407506.
[15] Pu K, Shi JH, Wang X, Tang Q, Wang XJ, Tang KL, et al. Diagnostic accuracy of transient 
elastography (FibroScan) in detection of esophageal varices in patients with cirrhosis: A 
meta-analysis. World Journal of Gastroenterology. 2017;23:345-356.
[16] Qu Y, Li T, Ye Q, Zhang L, Wang L. A beginning or the end? A meta-analysis to assess the 
diagnostic accuracy of transient elastography for the prediction of esophageal varices. 
Saudi Journal of Gastroenterology. 2016;22:345-352.
[17] Singh S, Eaton JE, Murad MH, Tanaka H, Iijima H, Talwalkar JA. Accuracy of spleen stiff-
ness measurement in detection of esophageal varices in patients with chronic liver dis-
ease: Systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. 
2014;12:935-945, e934.
[18] Ma X, Wang L, Wu H, Feng Y, Han X, Bu H, et al. Spleen stiffness is superior to liver stiff-
ness for predicting esophageal varices in chronic liver disease: A meta-analysis. PLoS 
One 2016;11:e0165786.
Alternative Diagnostic Tests of Gastroesophageal Varices in Liver Cirrhosis: Recent Advance
http://dx.doi.org/10.5772/intechopen.68418
83
[19] Colli A, Gana JC, Turner D, Yap J, Adams-Webber T, Ling SC, et al. Capsule endoscopy 
for the diagnosis of oesophageal varices in people with chronic liver disease or portal 
vein thrombosis. The Cochrane Database of Systemic Reviews. 2014:CD008760.
[20] McCarty TR, Afinogenova Y, Njei B. Use of wireless capsule endoscopy for the diagnosis 
and grading of esophageal varices in patients with portal hypertension: A systematic 
review and meta-analysis. Journal of Clinical Gastroenterology. 2017;51:174-182.
[21] Tseng YJ, Zeng XQ, Chen J, Li N, Xu PJ, Chen SY. Computed tomography in evalu-
ating gastroesophageal varices in patients with portal hypertension: A meta-analysis. 
Digestive and Liver Disease. 2016;48:695-702.
[22] Deng H, Qi X, Guo X. Computed tomography for the diagnosis of varices in liver cir-
rhosis: A systematic review and meta-analysis of observational studies. Postgraduate 
Medicine. 2017;129:318-328.
[23] Deng H, Qi X, Zhang Y, Peng Y, Li J, Guo X. Diagnostic accuracy of contrast-enhanced 
computed tomography for esophageal varices in liver cirrhosis: A retrospective observa-
tional study. Journal of Evidence Based Medicine. 2017;10:46-52.
[24] Wang AJ, Li BM, Zheng XL, Shu X, Zhu X. Utility of endoscopic ultrasound in the diagno-
sis and management of esophagogastric varices. Endoscopic Ultrasound. 2016;5:218-224.
Liver Cirrhosis - Update and Current Challenges84
